Ítem
Solo Metadatos
Mutant GNLY is linked to Stevens–Johnson syndrome and toxic epidermal necrolysis
dc.creator | Fonseca Mendoza, Dora Janeth | spa |
dc.creator | Caro L.A. | spa |
dc.creator | Sierra-Díaz D.C. | spa |
dc.creator | Serrano-Reyes C. | spa |
dc.creator | Londoño O. | spa |
dc.creator | Suárez Y.C. | spa |
dc.creator | Mateus H.E. | spa |
dc.creator | Bolívar-Salazar D. | spa |
dc.creator | Ramírez A.F. | spa |
dc.creator | de-la-Torre, Alejandra | spa |
dc.creator | Laissue P. | spa |
dc.date.accessioned | 2020-05-26T00:10:11Z | |
dc.date.available | 2020-05-26T00:10:11Z | |
dc.date.created | 2019 | spa |
dc.description.abstract | Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare severe cutaneous adverse reactions to drugs. Granulysin (GNLY) plays a key role in keratinocyte apoptosis during SJS/TEN pathophysiology. To determine if GNLY-encoding mutations might be related to the protein’s functional disturbances, contributing to SJS/TEN pathogenesis, we performed direct sequencing of GNLY’s coding region in a group of 19 Colombian SJS/TEN patients. A GNLY genetic screening was implemented in a group of 249 healthy individuals. We identified the c.11G > A heterozygous sequence variant in a TEN case, which creates a premature termination codon (PTC) (p.Trp4Ter). We show that a mutant protein is synthesised, possibly due to a PTC-readthrough mechanism. Functional assays demonstrated that the mutant protein was abnormally located in the nuclear compartment, potentially leading to a toxic effect. Our results argue in favour of GNLY non-synonymous sequence variants contributing to SJS/TEN pathophysiology, thereby constituting a promising, clinically useful molecular biomarker. © 2019, Springer-Verlag GmbH Germany, part of Springer Nature. | eng |
dc.format.mimetype | application/pdf | |
dc.identifier.doi | https://doi.org/10.1007/s00439-019-02066-w | |
dc.identifier.issn | 03406717 | |
dc.identifier.issn | 14321203 | |
dc.identifier.uri | https://repository.urosario.edu.co/handle/10336/24215 | |
dc.language.iso | eng | spa |
dc.publisher | Springer | spa |
dc.relation.citationEndPage | 1274 | |
dc.relation.citationIssue | No. 44176 | |
dc.relation.citationStartPage | 1267 | |
dc.relation.citationTitle | Human Genetics | |
dc.relation.citationVolume | Vol. 138 | |
dc.relation.ispartof | Human Genetics, ISSN:03406717, 14321203, Vol.138, No.44176 (2019); pp. 1267-1274 | spa |
dc.relation.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074025514&doi=10.1007%2fs00439-019-02066-w&partnerID=40&md5=1b915c3775dff3aa10c0cb5a8493e13b | spa |
dc.rights.accesRights | info:eu-repo/semantics/openAccess | |
dc.rights.acceso | Abierto (Texto Completo) | spa |
dc.source.instname | instname:Universidad del Rosario | spa |
dc.source.reponame | reponame:Repositorio Institucional EdocUR | spa |
dc.subject.keyword | Carbamazepine | spa |
dc.subject.keyword | preschool | eng |
dc.subject.keyword | differentiation | eng |
dc.subject.keyword | Cefalexin | spa |
dc.subject.keyword | human | eng |
dc.subject.keyword | Cocodamol | spa |
dc.subject.keyword | t-lymphocyte | eng |
dc.subject.keyword | Contrast medium | spa |
dc.subject.keyword | Cotrimoxazole | spa |
dc.subject.keyword | Granulysin | spa |
dc.subject.keyword | Lamotrigine | spa |
dc.subject.keyword | Metoclopramide | spa |
dc.subject.keyword | Phenytoin | spa |
dc.subject.keyword | Pyrimethamine plus sulfadoxine | spa |
dc.subject.keyword | Sulfonamide | spa |
dc.subject.keyword | Biological marker | spa |
dc.subject.keyword | Gnly protein | eng |
dc.subject.keyword | Mutant protein | spa |
dc.subject.keyword | T lymphocyte antigen | spa |
dc.subject.keyword | Adult | spa |
dc.subject.keyword | Animal cell | spa |
dc.subject.keyword | Article | spa |
dc.subject.keyword | Cellular distribution | spa |
dc.subject.keyword | Child | spa |
dc.subject.keyword | Cho cell line | spa |
dc.subject.keyword | Clinical article | spa |
dc.subject.keyword | Codon | spa |
dc.subject.keyword | Computer model | spa |
dc.subject.keyword | Female | spa |
dc.subject.keyword | Gene frequency | spa |
dc.subject.keyword | Gene mutation | spa |
dc.subject.keyword | Gene sequence | spa |
dc.subject.keyword | Heterozygote | spa |
dc.subject.keyword | Human | spa |
dc.subject.keyword | Male | spa |
dc.subject.keyword | Middle aged | spa |
dc.subject.keyword | Nonhuman | spa |
dc.subject.keyword | Nucleotide sequence | spa |
dc.subject.keyword | Pathogenesis | spa |
dc.subject.keyword | Pathophysiology | spa |
dc.subject.keyword | Preschool child | spa |
dc.subject.keyword | Priority journal | spa |
dc.subject.keyword | Protein localization | spa |
dc.subject.keyword | Sanger sequencing | spa |
dc.subject.keyword | School child | spa |
dc.subject.keyword | Stevens johnson syndrome | spa |
dc.subject.keyword | Toxic epidermal necrolysis | spa |
dc.subject.keyword | Urtica dioica | spa |
dc.subject.keyword | Western blotting | spa |
dc.subject.keyword | Young adult | spa |
dc.subject.keyword | Adolescent | spa |
dc.subject.keyword | Apoptosis | spa |
dc.subject.keyword | Case control study | spa |
dc.subject.keyword | Genetic predisposition | spa |
dc.subject.keyword | Genetics | spa |
dc.subject.keyword | Infant | spa |
dc.subject.keyword | Keratinocyte | spa |
dc.subject.keyword | Metabolism | spa |
dc.subject.keyword | Mutation | spa |
dc.subject.keyword | Necrosis | spa |
dc.subject.keyword | Pathology | spa |
dc.subject.keyword | Stevens johnson syndrome | spa |
dc.subject.keyword | Adolescent | spa |
dc.subject.keyword | Adult | spa |
dc.subject.keyword | Antigens | eng |
dc.subject.keyword | Apoptosis | spa |
dc.subject.keyword | Biomarkers | spa |
dc.subject.keyword | Case-control studies | spa |
dc.subject.keyword | Child | spa |
dc.subject.keyword | Child | eng |
dc.subject.keyword | Female | spa |
dc.subject.keyword | Genetic predisposition to disease | spa |
dc.subject.keyword | Humans | spa |
dc.subject.keyword | Infant | spa |
dc.subject.keyword | Keratinocytes | spa |
dc.subject.keyword | Male | spa |
dc.subject.keyword | Middle aged | spa |
dc.subject.keyword | Mutant proteins | spa |
dc.subject.keyword | Mutation | spa |
dc.subject.keyword | Necrosis | spa |
dc.subject.keyword | Stevens-johnson syndrome | spa |
dc.subject.keyword | Young adult | spa |
dc.title | Mutant GNLY is linked to Stevens–Johnson syndrome and toxic epidermal necrolysis | spa |
dc.type | article | eng |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | |
dc.type.spa | Artículo | spa |